Ad Stars: BBDO (Cypher)
DEVICE DTC
agency: BBDO
brand: Cypher
client: Cordis, a Johnson & Johnson company Agency team names withheld at client's request
A drug-eluding stent isn't something that's typically considered "patient's choice," so it seems counterintuitive to create consumer print ads to promote them. But to the surprise of industry watchers, that's just what BBDO did. Check out the agency's eye-catching campaign for Johnson & Johnson's Cypher stent, launched as full-page spreads in magazines and newspapers beginning in October 2007.
The spots feature people engaging in everyday physical activities, from jogging to playing with children. They also show the actual size of a stent and offer risk-and-benefit information. We like these ads because they educate consumers in an area where most say they don't need to be educated—and that's just nonsense. "It's up to the doctor to determine what's best for the patient, but we wanted to make sure the information was out there," said Cordis' Carol Goodrich, director of corporate communications. "It really is all about physician and patient interaction and conversation about coronary-artery disease."
PREVIOUS AGENCY ‹‹ HOME ›› NEXT AGENCY
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
